Dose escalation in prostate cancer with IMRT (76 GY-80 GY).: Acute and late toxicity.

被引:0
作者
Torrecilla, A. Lopez
Rosello, J.
Pastor, J.
Miragall, E. Garcia
Planas, D.
Hernandez, A.
机构
[1] Hosp Gen Univ, Valencia, Spain
[2] Hosp Gen Univ, Valencia, Spain
[3] Hosp Gen Univ, Valencia, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
487
引用
收藏
页码:S200 / S200
页数:1
相关论文
共 50 条
  • [31] Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy
    Peeters, STK
    Heemsbergen, WD
    Van Putten, WLJ
    Slot, A
    Tabak, H
    Mens, JW
    Lebesque, JV
    Koper, PCM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 1019 - 1034
  • [32] Assessment of late urinary, bowel and sexual function after dose escalation from 70 to 76 Gy using image-guided radiotherapy in curative treatment of prostate cancer
    Haugnes, Hege S.
    Melby, Bianca
    Larsen, Kari M.
    Langdal, Ingrid
    Rasi, Mana
    Bremnes, Roy M.
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2012, 46 (02): : 124 - 132
  • [33] Patterns of treatment failure in patients with prostate cancer treated with 76–80 Gy radiotherapy to the prostate and seminal vesicles ± hormonotherapy
    J. López-Torrecilla
    J. Pastor-Peidro
    A. Vicedo-González
    D. González-Sanchis
    A. Hernandez-Machancoses
    P. Almendros-Blanco
    E. García-Miragall
    J. C. Gordo-Partearroyo
    T. García-Hernández
    L. Brualla-González
    D. Granero-Cabañero
    J. Rosello-Ferrando
    Clinical and Translational Oncology, 2021, 23 : 481 - 490
  • [34] Chronic organ toxicity and quality of life after dose escalation in prostate cancer -: 74 Gy 3-D conformal therapy versus 46 Gy+HDR boost treatment
    Vordermark, D
    Wulf, J
    Markert, K
    Baier, K
    Kölbl, O
    Flentje, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 50 - 50
  • [35] Prospective study of quality of life for IMRT treatment of prostate cancer up to a total dose of 81 Gy
    Mikulik, O.
    Lilienthal, A.
    Hentschel, B.
    Weber, A.
    Oehler, W.
    Vordermark, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 65 - 65
  • [36] Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer
    Céline Mirjolet
    Paul M. Walker
    Mélanie Gauthier
    Cécile Dalban
    Suzanne Naudy
    Frédéric Mazoyer
    Etienne Martin
    Philippe Maingon
    Gilles Créhange
    Radiation Oncology, 11
  • [37] Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer
    Mirjolet, Celine
    Walker, Paul M.
    Gauthier, Melanie
    Dalban, Cecile
    Naudy, Suzanne
    Mazoyer, Frederic
    Martin, Etienne
    Maingon, Philippe
    Crehange, Gilles
    RADIATION ONCOLOGY, 2016, 11
  • [38] Gradual Dose Escalation to 80.5 Gy with Head and Neck Cancer in the ESCALOX Study - IMRT Planning with SIB in 3 Steps
    Schill, S.
    Kampfer, S.
    Molls, M.
    Pigorsch, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 98 - 99
  • [39] Comparison of High-Dose IMRT (86.4 Gy) to Combined Brachytherapy Plus IMRT for Intermediate-Risk Prostate Cancer
    Spratt, D. E.
    Kollmeier, M.
    Zumsteg, Z.
    Pirus, G.
    Yamada, Y.
    Cohen, G.
    Polkinghorn, W.
    Pei, X.
    Zelefsky, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S127 - S127
  • [40] 70 Gy or more: which dose for which prostate cancer?
    Ganswindt, U
    Paulsen, F
    Anastasiadis, AG
    Stenzl, A
    Bamberg, M
    Belka, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (07) : 407 - 419